Tuesday, November 19, 2024
HomeIndustriesHealthcare

Healthcare

AHF: WHO’s Monkeypox Name Game is Mistimed

AIDS Healthcare Foundation called on the World Health Organization (WHO) to prioritize implementing proven public health measures to curb the global spread of monkeypox,...

Avails Medical announces the commencement of U.S. Pivotal Clinical Trials for eQUANT

Avails Medical, a pioneer in rapid, automated and fully electrical antibiotic susceptibility testing (eAST™) announced the commencement of U.S. pivotal clinical trials for its...

Pneumagen Announces First Patient Dosed in Phase 2 Proof of Concept

Pneumagen, a clinical stage biotech company developing Neumifil, an intranasal, broad-spectrum antiviral treatment to prevent or, if infected reduce and manage viral respiratory tract...

Sirnaomics Develops Peptide Docking Vehicle (PDoV(TM)) Designed

Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced that the Company has developed a Peptide Docking Vehicle (PDoV™)...

Bridge Biotherapeutics Receives FDA Authorization to Proceed with Phase 2 Study

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company developing novel drugs for cancer, fibrosis and inflammation, announced it has received notice from the...
0FansLike
0FollowersFollow
spot_img

Hot Topics